Thank you, Madam Chair.
Thank you to our witnesses for joining us this afternoon. There is certainly a varied amount of opinions and commentary, which is always nice to hear when we're discussing important legislation such as this.
I want to start with a couple of questions for Dr. Geist and Ms. Gerson. Both of you mentioned in your opening statements the idea of the value proposition or where the intrinsic value comes from. Dr. Geist, you talked about the difference between reproduction and facilitating access. Both of you made various commentary related to that side of things.
Professor Geist, could you expand on that a little bit? Is this bill perhaps going down a slightly skewed path in terms of where the funding will be directed?